AU Patent

AU2007329895A1 — Crystalline form of 1- (beta-D-glucopyranosyl) -4 -methyl- 3- [5- (4 -fluorophenyl) -2-thienylmethyl] benzene hemihydrate

Assigned to Tanabe Pharma Corp · Expires 2008-06-12 · 18y expired

What this patent protects

Patent listed against Invokana.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007329895A1
Jurisdiction
AU
Classification
—
Expires
2008-06-12
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.